American International Gr... (AIG)
NYSE: AIG
· Real-Time Price · USD
80.42
0.11 (0.14%)
At close: Aug 15, 2025, 12:30 PM
American International Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| General Insurance Segment Revenue | 27.71B | 479M | 392M | 28.36B | 26.59B | 29.88B |
| General Insurance Segment Revenue Growth | +5685.39% | +22.19% | -98.62% | +6.67% | -11.03% | n/a |
| Corporate Nonsegment and Reconciling Items Revenue | 870M | 28.54B | 27.72B | 347M | 1.39B | 3.06B |
| Corporate Nonsegment and Reconciling Items Revenue Growth | -96.95% | +2.94% | +7889.05% | -74.95% | -54.74% | n/a |
| Total Reconciling Items Revenue | -548M | -1.08B | 10.67B | 3.75B | -995M | 836M |
| Total Reconciling Items Revenue Growth | -49.17% | -110.10% | +184.13% | -477.39% | -219.02% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|
| International Revenue | 14.22B | 13.24B | 14.83B | 16.39B | 15.37B |
| International Revenue Growth | +7.43% | -10.75% | -9.48% | +6.60% | n/a |
| North America Revenue | 13.03B | 33.56B | 41.6B | 31B | 34.15B |
| North America Revenue Growth | -61.18% | -19.32% | +34.20% | -9.21% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.16B | 1.11B | 1.33B | 1.35B | 1.61B | 2.01B | 2.13B | 1.31B | 1.49B | 1.98B | 2.7B | 2.08B | 2.21B | 2.16B | 2.24B | 2.24B | 2.22B | 2.09B | 2.17B | 1.99B | 2.09B | 2.15B | 2.16B | 2.19B | 2.14B | 2.05B | 2.38B | 2.33B | 2.32B | 2.27B | 2.33B | 2.15B | 2.18B | 2.44B | 2.86B | 2.54B | 2.59B | 3B | 3.47B | 3.17B | 3.09B | 2.95B |
| Selling, General, and Administrative Revenue Growth | +4.22% | -16.48% | -0.82% | -16.40% | -20.06% | -5.62% | +62.78% | -12.25% | -24.55% | -26.61% | +30.02% | -5.94% | +1.94% | -3.57% | +0.18% | +0.99% | +6.23% | -3.56% | +8.74% | -4.60% | -3.07% | -0.19% | -1.37% | +2.20% | +4.24% | -13.85% | +2.49% | +0.09% | +2.29% | -2.66% | +8.56% | -1.51% | -10.68% | -14.70% | +12.93% | -1.93% | -13.89% | -13.51% | +9.35% | +2.75% | +4.78% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |